Medical Press Release - Page 4 of 12 - Medika Life : Keeping you informed

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Lover, the App That Helps Women Reach Orgasm

Medika Life - October 22, 2020

There are tens of millions of women in the U.S. who have never had an orgasm or who are almost always left feeling unfulfilled by their sexual encounters

Research into gut microbiome-autism link reveals new perspective

Medika Life - November 12, 2021

Latest research on the gut biome and Autism fails to demonstrate a an association between the microbiome and a diagnosis of ASD

FREOPP Study: How New York’s Single Payer Health Care Bill Affects the Working Poor

Medika Life - May 13, 2021

The flawed design of the New York Health Act would be felt most acutely by low-income New Yorkers, a new FREOPP study finds. This Single-Payer Health

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

LATEST

TRENDING

Medika’s Call for Food Aid for Starving Filipino Children

Lover, the App That Helps Women Reach Orgasm

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

The 50 Most Influential Leaders in Pharmacy 2022 Awards

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

South University Announces New MSPA Program at West Palm Beach Campus

FINN Partners Brings Aboard the Pharmacy Podcast Network

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

EDITORS CHOICE

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Lover, the App That Helps Women Reach Orgasm

Research into gut microbiome-autism link reveals new perspective

FREOPP Study: How New York’s Single Payer Health Care Bill Affects the Working Poor

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories